Aletta has been with MilliporeSigma for 10 years in the Life Science business field, and currently manages process development and collaboration projects to advance cell therapy manufacturing.  Aletta brings expertise in cell culture media formulation and single-use bioreactor systems for use in a complex regulatory environment.  Previous roles at MilliporeSigma include scientist in R&D and Field Marketing supporting small-scale chromatography devices and cell culture products for monoclonal antibody production.  Aletta received her Ph.D. in 2007 from Boston University School of Medicine in the fields of immunology and neuroscience, focusing on trophic factors that influence immune cell activation, as well as neural differentiation and maintenance of phenotype.